Evidence map›Paper›PMID 32929089›Full record

SynthesisNature communications2020

An investigation of causal relationships between prediabetes and vascular complications.

Pascal M Mutie, Hugo Pomares-Millan, Naeimeh Atabaki-Pasdar, Nina Jordan, Rachel Adams, Nicole L Daly, Juan Fernandes Tajes, Giuseppe N Giordano, Paul W Franks

Erratum issuedOpen access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Modern-Day Management of the Dysglycemic Continuum: An Expert Viewpoint from the Arabian Gulf.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Pascal M Mutie *Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.
Hugo Pomares-Millan *Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.ORCID http://orcid.org/0000-0001-9245-4576
Naeimeh Atabaki-PasdarGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.
Nina JordanRegulatory Affairs Intelligence, Novo Nordisk A/S, Copenhagen, Denmark.
Rachel AdamsRegulatory Affairs-Neuroscience and Cardiovascular Metabolism, Janssen, High Wycombe, UK.ORCID http://orcid.org/0000-0003-0455-6447
Nicole L DalyRegulatory Affairs-Neuroscience and Cardiovascular Metabolism, Janssen, High Wycombe, UK.
Juan Fernandes TajesGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.
Giuseppe N GiordanoGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden.ORCID http://orcid.org/0000-0002-6719-6680
Paul W FranksGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Clinical Research Centre, Lund University, Skåne University Hospital, Jan Waldenströms gata 35, Malmö, SE-20502, Sweden. paul.franks@med.lu.se.ORCID http://orcid.org/0000-0002-0520-7604
Lund University · SEJanssen (United Kingdom) · GBHarvard University · USNovo Nordisk (Denmark) · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prediabetes is a state of glycaemic dysregulation below the diagnostic threshold of type 2 diabetes (T2D). Globally, ~352 million people have prediabetes, of which 35-50% develop full-blown diabetes within five years. T2D and its complications are costly to treat, causing considerable morbidity and early mortality. Whether prediabetes is causally related to diabetes complications is unclear. Here we report a causal inference analysis investigating the effects of prediabetes in coronary artery disease, stroke and chronic kidney disease, complemented by a systematic review of relevant observational studies. Although the observational studies suggest that prediabetes is broadly associated with diabetes complications, the causal inference analysis revealed that prediabetes is only causally related with coronary artery disease, with no evidence of causal effects on other diabetes complications. In conclusion, prediabetes likely causes coronary artery disease and its prevention is likely to be most effective if initiated prior to the onset of diabetes.

Indexed as

Blood GlucoseCardiovascular DiseasesConfidence IntervalsCoronary Artery DiseaseDiabetes Mellitus, Type 2FastingHumansMiddle AgedObservational Studies as TopicOdds RatioPrediabetic StateRenal Insufficiency, ChronicRisk FactorsStrokeBlood Glucose

Identifiers

PMID32929089
PMCPMC7490420
OpenAlexW3085593560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.